OWL-EVO1

· Owlstone Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OWL-EVO1, covering 2024-10-15 to 2024-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2) [Phase 2]